358 related articles for article (PubMed ID: 11739151)
1. Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome.
Maciejewski JP; Follmann D; Nakamura R; Saunthararajah Y; Rivera CE; Simonis T; Brown KE; Barrett JA; Young NS
Blood; 2001 Dec; 98(13):3513-9. PubMed ID: 11739151
[TBL] [Abstract][Full Text] [Related]
2. Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol-anchored protein-deficient clones.
Maciejewski JP; Rivera C; Kook H; Dunn D; Young NS
Br J Haematol; 2001 Dec; 115(4):1015-22. PubMed ID: 11843844
[TBL] [Abstract][Full Text] [Related]
3. Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone.
Maciejewski JP; Sloand EM; Sato T; Anderson S; Young NS
Blood; 1997 Feb; 89(4):1173-81. PubMed ID: 9028939
[TBL] [Abstract][Full Text] [Related]
4. HLA class II haplotype and quantitation of WT1 RNA in Japanese patients with paroxysmal nocturnal hemoglobinuria.
Shichishima T; Okamoto M; Ikeda K; Kaneshige T; Sugiyama H; Terasawa T; Osumi K; Maruyama Y
Blood; 2002 Jul; 100(1):22-8. PubMed ID: 12070003
[TBL] [Abstract][Full Text] [Related]
5. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes.
Dunn DE; Tanawattanacharoen P; Boccuni P; Nagakura S; Green SW; Kirby MR; Kumar MS; Rosenfeld S; Young NS
Ann Intern Med; 1999 Sep; 131(6):401-8. PubMed ID: 10498555
[TBL] [Abstract][Full Text] [Related]
6. Killer immunoglobulin-like receptor genotype in immune-mediated bone marrow failure syndromes.
Howe EC; Wlodarski M; Ball EJ; Rybicki L; Maciejewski JP
Exp Hematol; 2005 Nov; 33(11):1357-62. PubMed ID: 16263420
[TBL] [Abstract][Full Text] [Related]
7. Paroxysmal nocturnal hemoglobinuria with copy number-neutral 6pLOH in GPI (+) but not in GPI (-) granulocytes.
Ueda Y; Nishimura J; Murakami Y; Kajigaya S; Kinoshita T; Kanakura Y; Young NS
Eur J Haematol; 2014; 92(5):450-3. PubMed ID: 24931618
[TBL] [Abstract][Full Text] [Related]
8. HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome.
Saunthararajah Y; Nakamura R; Nam JM; Robyn J; Loberiza F; Maciejewski JP; Simonis T; Molldrem J; Young NS; Barrett AJ
Blood; 2002 Sep; 100(5):1570-4. PubMed ID: 12176872
[TBL] [Abstract][Full Text] [Related]
9. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.
Wanachiwanawin W; Siripanyaphinyo U; Piyawattanasakul N; Kinoshita T
Eur J Haematol; 2006 Jun; 76(6):502-9. PubMed ID: 16529603
[TBL] [Abstract][Full Text] [Related]
10. Screening for paroxysmal nocturnal hemoglobinuria (PNH) clone in Egyptian children with aplastic anemia.
Rizk S; Ibrahim IY; Mansour IM; Kandil D
J Trop Pediatr; 2002 Jun; 48(3):132-7. PubMed ID: 12164595
[TBL] [Abstract][Full Text] [Related]
11. NKG2D-mediated immunity underlying paroxysmal nocturnal haemoglobinuria and related bone marrow failure syndromes.
Hanaoka N; Nakakuma H; Horikawa K; Nagakura S; Tsuzuki Y; Shimanuki M; Kojima K; Yonemura Y; Kawaguchi T
Br J Haematol; 2009 Sep; 146(5):538-45. PubMed ID: 19594748
[TBL] [Abstract][Full Text] [Related]
12. [Expression of three kinds of GPI-anchor proteins in paroxysmal nocturnal hemoglobinuria, aplastic anemia and myelodysplastic syndromes patients and their clinical implications].
Dong XY; Xu CG; Sun GR; Zhang T; Peng J
Zhonghua Xue Ye Xue Za Zhi; 2004 Apr; 25(4):198-201. PubMed ID: 15182554
[TBL] [Abstract][Full Text] [Related]
13. A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.
Shichishima T; Noji H
Hematology; 2002 Aug; 7(4):211-27. PubMed ID: 14972783
[TBL] [Abstract][Full Text] [Related]
14. Aplastic anemia and paroxysmal nocturnal hemoglobinuria: search for a pathogenetic link.
Griscelli-Bennaceur A; Gluckman E; Scrobohaci ML; Jonveaux P; Vu T; Bazarbachi A; Carosella ED; Sigaux F; Socié G
Blood; 1995 Mar; 85(5):1354-63. PubMed ID: 7858265
[TBL] [Abstract][Full Text] [Related]
15. Polyclonal hematopoiesis maintained in patients with bone marrow failure harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells.
Ishiyama K; Chuhjo T; Wang H; Yachie A; Omine M; Nakao S
Blood; 2003 Aug; 102(4):1211-6. PubMed ID: 12676778
[TBL] [Abstract][Full Text] [Related]
16. High frequency of several PIG-A mutations in patients with aplastic anemia and myelodysplastic syndrome.
Okamoto M; Shichishima T; Noji H; Ikeda K; Nakamura A; Akutsu K; Maruyama Y
Leukemia; 2006 Apr; 20(4):627-34. PubMed ID: 16467865
[TBL] [Abstract][Full Text] [Related]
17. Immune pathogenesis of paroxysmal nocturnal hemoglobinuria.
Tiu R; Maciejewski J
Int J Hematol; 2006 Aug; 84(2):113-7. PubMed ID: 16926131
[TBL] [Abstract][Full Text] [Related]
18. Relationship between aplastic anemia and paroxysmal nocturnal hemoglobinuria.
Kinoshita T; Inoue N
Int J Hematol; 2002 Feb; 75(2):117-22. PubMed ID: 11939256
[TBL] [Abstract][Full Text] [Related]
19. Relative increase of granulocytes with a paroxysmal nocturnal haemoglobinuria phenotype in aplastic anaemia patients: the high prevalence at diagnosis.
Wang H; Chuhjo T; Yamazaki H; Shiobara S; Teramura M; Mizoguchi H; Nakao S
Eur J Haematol; 2001 Mar; 66(3):200-5. PubMed ID: 11350489
[TBL] [Abstract][Full Text] [Related]
20. A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure.
Raza A; Ravandi F; Rastogi A; Bubis J; Lim SH; Weitz I; Castro-Malaspina H; Galili N; Jawde RA; Illingworth A
Cytometry B Clin Cytom; 2014 May; 86(3):175-82. PubMed ID: 24227693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
